Monopar Therapeutics Inc (NQ: MNPR )
0.6582
+0.0307
(+4.89%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Apr 26, 2024
Add to My Watchlist
Headline News about Monopar Therapeutics IncVia Benzinga
Via Benzinga
Via Benzinga
Monopar Stock Gains On Launch Of Early Stage Soft Tissue Cancer Trial With Camsirubicin
August 03, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|